News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Medical Ventures Corp. (MEV) Begins FDA Submission Process For Metricath Gemini



8/27/2007 8:25:26 AM

RICHMOND, BRITISH COLUMBIA--(Marketwire - Aug. 27, 2007) - MEDICAL VENTURES CORP. (TSX VENTURE:MEV - News) has submitted to the U.S. Food and Drug Administration the first of three modules of a pre-market approval (PMA) application for coronary use of the Metricath GeminiĀ® catheter. Submitting the PMA application module initiates the process to obtain FDA approval for the medical device.

Read at Market Wired


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES